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Abstract
Sequences governing RNA splicing are difficult to study in situ due to the great difficulty of traditional targeted
mutagenesis. Zinc-finger nuclease (ZFN) technology allows for the rapid and efficient introduction of site-specific mutations
into mammalian chromosomes. Using a ZFN pair along with a donor plasmid to manipulate the outcomes of DNA repair, we
introduced several discrete, targeted mutations into the fourth intron of the endogenous BAX gene in Chinese hamster
ovary cells. Putative lariat branch points, the polypyrimidine tract, and the splice acceptor site were targeted. We recovered
numerous otherwise isogenic clones carrying the intended mutations and analyzed the effect of each on BAX pre-mRNA
splicing. Mutation of one of three possible branch points, the polypyrimidine tract, and the splice acceptor site all caused
exclusion of exon five from BAX mRNA. Interestingly, these exon-skipping mutations allowed usage of cryptic splice
acceptor sites within intron four. These data demonstrate that ZFN-mediated gene editing is a highly effective tool for
dissection of pre-mRNA splicing regulatory sequences in their endogenous context.
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Introduction
The use of mutagenesis to reveal gene function is a classic
technique in biology. The difficulty of achieving targeted
mutagenesis in mammalian cells often has necessitated the use of
extra-chromosomal or randomly-integrated reporter constructs as
a proxy for endogenous gene function. While reporter-based
experiments have contributed immensely to our understanding of
the cell, loss of correct gene dosage, regulation, and chromatin
structure can misrepresent the biology of the endogenous gene. In
the case of RNA splicing, use of reporter genes can be unusually
problematic as splicing is influenced or regulated by large-scale
processes like chromatin modification [1,2,3,4,5], transcription
[6,7,8,9,10,11,12], and mRNA export [13,14]. Furthermore, the
large size of mammalian genes often simply precludes the use of
reporter systems to analyze splicing. Retrospective analysis of
splicing in cells with naturally-occurring mutations has been
informative but is not compatible with directed experimentation
and lacks appropriate isogenic controls [15,16,17]. Given the
centrality of alternative splicing to metazoan biology and disease,
techniques that allow investigation of splicing regulation in its
natural context are sorely needed.
A ZFN pair creates a targeted double-strand break in
chromosomal DNA. When repaired inaccurately by the non-
homologous end joining (NHEJ) DNA repair machinery, gene
disruption results [18,19,20,21]. Alternately, the homology-
directed DNA repair (HDR) pathway can be manipulated to
engineer mutations into endogenous genomic loci [22,23,24,25].
In this application, a plasmid with chromosomal DNA sequence
flanking the ZFN cleavage site and containing the desired
mutation is co-delivered with the ZFNs. The cell can use this
donor molecule as a template for DNA repair, resulting in copying
of the mutated region into the chromosome (Figure 1A).
The BAX gene is haploid in CHO cells and its mutation by
NHEJ can result in loss of a splice acceptor site resulting in
skipping of exon five [26]. We reasoned that engineered
mutagenesis of the endogenous gene via HDR would allow us to
dissect the sequences required for normal BAX splicing. Here we
demonstrate the utility of ZFNs to reveal splice site sequences. We
introduce six mutations into intron four of the endogenous BAX
gene and assay their effect on splicing by RT-PCR and high-
throughput sequencing. Notably, our targeted mutagenesis
identifies the branch point nucleotide for intron four lariat
formation and uncovers cryptic splice acceptor regions within
intron four, providing the first in situ functional annotation of splice
site sequences in mammalian cells.
Methods
Donor plasmid design and construction
Donor plasmids were created with BAX homology regions on
either side of the targeted mutations using fusion PCR. Each
homology arm was synthesized separately by PCR amplification of
BAX genomic DNA with a distal primer and a central primer
containing the targeted mutation. For the initial round of PCR,
the left homology arms were synthesized using GJC 47F (59-cag
aag ttc aag att ggc tta c-39) and a mutation-specific reverse primer
while right homology arms were created with a partially-
complementary mutation-specific forward primer and GJC 114R
(59-tga acc agg ctg gga gat tt -39). Annealing of the complementary
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16961Figure 1. Alteration of BAX pre-mRNA splicing in response to mutagenesis of key cis regulatory splicing sequences. A) Diagram of
homology-directed repair in the BAX exon five region. Cleavage at the end of exon five stimulates strand invasion by the resected single-strand DNA.
Once base pairing is established between the chromosome and the donor, new DNA synthesis and repair of the break using the newly synthesized
DNA results in incorporation of the mutated sequence into the chromosome. Thick black lines, homology between the chromosome (top) and the
donor plasmid (bottom); black arrow, strand invasion and new DNA synthesis; grey patch in donor plasmid and new DNA, mutation. Exon five and
the donor sequence are drawn to scale. B) Putative splice site sequences found within the 39 end of BAX intron four. Potential lariat branch points, the
polypyrimidine tract, and the splice acceptor site in BAX intron four are indicated with black bars. The site of ZFN cleavage (shown in grey) is
approximately 90 bp from the end of exon five. C) Mutations introduced into BAX intron four and their effect on BAX splicing. The location of specific
base changes made in each isogenic cell line are shown in grey. For the branch point C mutation, the terminal C of the consensus sequence shown in
part A was not altered. Arrows link the mutation with the gel lane containing RT-PCR products from a cell clone bearing the corresponding mutation.
Lane 1; wild-type CHO-K1 cells; lane 2, branch point A mutation; lane 3, branch point B mutation; lane 4, branch point C mutation; lane 5, mutation of
branch point C and the polypyrimidine tract (top); lane 6, mutation of the polypyrimidine tract (bottom); lane 7, splice acceptor mutation; lane 8, no
template control. The identity and size of bands excised and confirmed by Sanger sequencing is shown to the right of the gel. High-molecular weight
bands present in lanes 4–7 are heteroduplex material formed late in the PCR reaction by annealing of normal and exon five-skipped RT-PCR products.
Molecular weight markers are in base pairs. The splicing pattern for each mutation was assayed between 4 and 12 times; representative data are
shown. D) RT-PCR of the wild-type BAK gene in all eight samples serves as a loading control and is shown below the BAX RT-PCR.
doi:10.1371/journal.pone.0016961.g001
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PCR created a 882 bp region of homology with a central intronic
mutation. This second PCR was done using two primers inside
GJC 47F and GJC 114R, namely GJC 250F (59-cca gcc tgg ttt aca
cag at-39) and GJC 249R (59-ggt tct gca taa gtg gtt ct-39). Each
resulting amplicon was cloned into the pCR2.1 vector (Invitrogen)
and clones confirmed by DNA sequencing. All PCR amplifications
were done with Accuprime Taq Hi Fidelity DNA Polymerase
(Invitrogen) per the manufacturer’s recommendations.
Mutation-specific oligonucleotides are shown below with muta-
tions in bold. For the branch point A donor, the left homology arm
wascreatedbyPCRoftheBAXlocuswithGJC47FandSC12R#3
(59-agt cct tcga a ca c tc c tg g ag a ag g tg g t - 3 9); the right homology
arm by PCR with SC 13F #3( 5 9-agt gtt cga agg act cag tcc tcc cgt
gt-39) and GJC 114R. The branch point B donor was made as above
but using SC 12R (59-ggg agg acc gag tcc tgt gaa cac tcc tgg-39 and
SC13F(59-ggactcggtcctcccgtgtaaccttccca-39).Thebranchpoint
C donor was made as above but using SC 12R #2( 5 9-aggc ta gcc
ggg agg act gag tcc tgt gaa-39) and SC 13F #2( 5 9-cct ccc ggc tagc ct
tcc cac tcc ctg cag-39). The pY tract donor with AG dinucleotides
was made as above but using SC 14R (59-gct ctc ctt tct ctt ctt aca
cgg gaggac tgag-39) andSC15F(59- gaa gag aaa gga gagcaggcc
ctg tgt acc aaa g -39). The pY tract donor with no AG dinucleotides
was made as above but with SC 14_2R (59-tgc cat cat ttt cca tct
tacacgggaggactga-39)andSC15_2F(59-gatggaaaatgatggcag
gcc ctg tgt acc aaa g-39). The splice acceptor donor was made as
above but with SC 16R (59- cag ggc ccg cag gga gtg gga agg tta-39
and SC 17F (59-t c cc t gc gg gcc ctg tgt acc aaa gtg-39).
Transfection and cell cloning
CHO-K1 cells were obtained from the American Type Culture
Collection (ATCC CCL-61) and grown and transfected with the
FokI EL/KK heterodimer mutant BAX ZFNs as described
previously (Figure S1) [26]. Twenty micrograms of donor was
cotransfected with the ZFNs. Genomic DNA of the transfected
pools was extracted from the aforementioned samples using the
Masterpure kit (Epicentre). Each sample was PCR-amplified using
GJC 47F and GJC 114R, oligonucleotides outside of the donor
sequence. This PCR was used to analyze BAX ZFN action via the
Cel I assay and to analyze the extent of targeted mutation by assay
of restriction fragment length polymorphism (RFLP). For the Cel I
assay, a nested PCR was performed with a primer closer to the ZFN
sites, GJC 52F (59- cag agg aat gaa agc aaa gg-39), and GJC 114R.
The percentage of modified cells was calculated as described
previously [19,26]. For the RFLP assay, each donor was designed so
that the targeted mutation either deletes or creates a new restriction
site relative to the unmodified sequence. The branch point A
mutation creates a BstBI site; the branch point B mutation creates a
Sau961 site; the branch point C mutation creates an NheI site; the
two polyY tract mutations and the splice acceptor mutation delete a
PstI site. Digestion with the corresponding diagnostic restriction
enzyme indicated the extent of specific modification by HDR.
For cell cloning, each co-transfected pool was diluted to 0.4
cells/well in 96-well plates. After approximately 2 weeks of growth,
samples from each occupied well were harvested and genomic
DNA isolated using the Epicentre QuickExtract Solution. Each
sample was PCR amplified with GJC 47F and GJC 114R and
analyzed by the RFLP assay described above. Positive clones were
expanded and then genotyped by DNA sequencing.
RNA analysis
Total RNA was prepared from each clone with the High Pure
RNA Isolation Kit (Roche). Complementary DNA was synthe-
sized using a polydT oligonucleotide to prime reverse transcription
by the SuperScript III RT (Invitrogen). For analysis of BAX, the
cDNA from each clone was PCR amplified using GJC 12F (in
exon four, 59-ctt ctt ccg tgt ggc agc tg-39) and GJC 23R (in exon
six, 59-ccc gaa gta tga gag gag gcc atc -39), and PCR analyzed by
electrophoresis on 10% polyacrylamide gels. The identity of each
BAX cDNA band annotated in Figure 1 was confirmed by Sanger
DNA sequencing. For analysis of BAK, cDNA was PCR amplified
using GJC164F (in exon 1, 59-cgg gat ctt tgt ctt cag ac-39) and GJC
25R (in exon 4, 59-ctg gaa ctc tgt gtc gta tct ccg g-39).
High-throughput DNA sequencing
Solexa/Illumina-based DNA sequencing was performed on a
pool of RT-PCR products from the clone in lane six (the
polypyrimidine tract mutation containing AG dinucleotides).
cDNA from this clone was PCR amplified with a forward
oligonucleotide in exon four (59- aat gat acg gcg acc acc gag atc tac
act ctt tcc cta cac gac gct ctt ccg atc tag caa act ggt gct caa g-
39) and a reverse oligonucleotide in exon 6 (59-caa gca gaa gac ggc
ata cga gct ctt ccg atc taa gta tga gag gag gcc atc-39) where
bold font indicates homology to BAX genomic DNA. The
amplicon was purified first with the Qiaquick PCR Purification
kit (Qiagen) then with the GeneJET Purification Protocol
(Fermentas).
Results
The splicing machinery recognizes several key splice site
sequences in pre-mRNA to effect intron removal. In brief, binding
of U2AF to the polypyrimidine tract promotes formation of a 59-29
lariat linkage between the splice donor site and the branch point
nucleotide. The resulting lariat molecule is excised by nucleophilic
attack of the splice acceptor site by the upstream exon. Potential
lariat branch points, polypyrimidine tracts, and splice acceptor
sites in BAX intron four were identified computationally by the
Sroogle algorithm and by visual inspection (Figure 1B)
[27,28,29,30]. Six donor plasmids were assembled, each contain-
ing 882 bp of flanking BAX genomic DNA along with six separate
mutated regions designed to disrupt each of three potential lariat
branch points, the polypyrimidine tract (two mutations), and the
splice acceptor site, respectively. BAX ZFNs were transfected into
CHO-K1 cells with each individual donor plasmid. Mutation at
BAX three days post-transfection was 6.3+/22.0% (n=6) of alleles
as measured by the Cel I assay [19]. The transfected pool was
cloned by limiting dilution and BAX PCR products from each
clone screened for the gain or loss of a restriction site generated by
the intended mutation in BAX intron four. The genotype of
positive clones was confirmed by DNA sequencing. Across all six
transfections, correct clones were recovered at a frequency of
0.3+/20.2% (n=6; see Discussion).
RNA was prepared from wild-type CHO-K1 cells and from one
representative clone for each of the six mutations. RT-PCR was
performed using primers in exons four and six. Analysis of PCR
products for each mutation revealed the contribution of each
sequence to the correct splicing of exon five (Figure 1C). Firstly,
mutation of putative branch points A and B did not affect splicing.
Both mutants resulted in a single RT-PCR band indistinguishable
from that in wild-type cells, demonstrating that genome editing per
se does not alter RNA splicing. In contrast, loss of branch point C
caused an approximate 50% loss of exon five from the BAX
transcript (lane 4). Both mutations of the polypyrimidine tract
resulted in very significant loss of correct splicing (,90%, lanes
5,6). As expected, a single nucleotide change in the highly-
conserved splice acceptor site completely prevented splicing of
exon five (lane 7). The level of BAK mRNA (an unmodified, wild-
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BAX (Figure 1D).
Certain mutations caused the appearance of or an increase in of
minor splice forms (lanes 4–7). To sample splice form diversity, we
subjected RT-PCR products from lane six to high-throughput DNA
sequencing using a forward primer placed at the very end of exon four.
Five different transcripts containing varying lengths of the 39 end of
intron four were found: inclusion of 153, 50, 38, 142, and 31 bp, in
order of approximate frequency. All such cryptic splice sites are
immediately preceded by an YAG splice acceptor sequence. Clearly
visible in lanes 4–7, the most abundant cryptic splice site (379 bp band)
has a well-positioned YUNAY branch point consensus and polypyr-
imidine tract (cttac-ctcttccctgccttcc-ag). None of the mRNAs derived
from cryptic splicing result in a 59 extension of the normal BAX exon 5
open reading frame; all transcripts except the rarest 31 bp extension
should be degraded by nonsense-mediated mRNA decay.
Taken together, these data demonstrate the successful creation
of isogenic CHO cells carrying an allelic series of mutations
implicated in the regulation of splicing at the endogenous BAX
gene. Our data reveal the critical importance of just one of three
potential branch points, the polypyrimidine tract and the splice
acceptor sequence in the maintenance of normal exon five
splicing. Moreover, these data reveal cryptic splice sites in intron
four active only when the preferred natural site is mutated.
Discussion
Experiments done in vitro and in yeast have informed our
knowledge of splicing biology enormously, yet understanding has
been hampered in most organisms by a simple inability to perform
targeted mutagenesis.Such a facility would be particularlyuseful for
understanding the integration of splicing with chromatin remodel-
ing and transcription and for studying the alternative splicing that
accounts for a large part of biological diversity in higher eukaryotes.
We performed ZFN-mediated targeted mutagenesis of the C. griseus
BAX gene to dissect the importance of various splice site sequences
in their normal, endogenous chromosomal context. Traditional
recombination is also capable of creating site-specific mutations in
endogenous genes but is laborious and time-consuming. In contrast,
the mutations described here were created in two overlapping
tranches, each of ,10 weeks in duration, from donor creation to
isolation of the final clones. Most of this period involved clone
growth and expansion and therefore little investigator effort. The
inefficiency of traditional homologous recombination necessitates
co-integration of a selectable marker gene. The ability to obtain the
desired mutations without the use of a selectable marker obviates
concerns about the confounding impact of such an exogenous,
independent transcription unit.
The conversion efficiency of double-strand breaks into correctly
mutated alleles in this experiment was much lower than the amount
of ZFN cleavage (6.3% cleavage, 0.3% conversion) and lower than
the ,33% of breaks typically converted into targeted integrations
[25], (data not shown). This is likely the result of the ,110 bp
between the site of the ZFN-induced break and the site of the
intended mutations. Because of this distance, the break can be
repaired successfully without single-strand extension long enough to
reach the mutated site in the donor plasmid. ZFNs can be targeted
to essentially any DNA sequence. Use of a custom ZFN pair
positioned more closely to the target area should substantially
improve the relative frequency of mutated clones. Furthermore,
only 39 end invasion from the right sideof the break will result in the
introduction of the mutation. (Invasion from the left will copy only
wild-type sequence from the donor plasmid.) Despite the modest
overall efficiency of mutagenesis, we were still able to isolate the
desired mutants in a single round of experimentation.
BAX is naturally haploid in CHO cells. Exon five is in frame
with exon four and the terminal exon six; transcripts lacking exon
five will therefore not be subject to nonsense-mediated mRNA
decay and will provide an unbiased readout of BAX splicing.
Interrogation of most other genes will require a similar choice of
an in-frame exon and the generation of homozygous mutant cells.
Homozygotes are typically formed at a approximately one-third
the frequency of heterozygous mutants or can be made via a
second round of ZFN mutagenesis [23]. Alternately, the
complications of diploidy can be avoided by use of a near-haploid
cell line such as the human leukemia line P1-55 [31].
Mutation of branch point consensus C resulted in an incompletely
penetrant splicing phenotype. We suspect that an second lariat
branch point was used to produce the correctly-spliced fraction of
BAX mRNA,perhaps sites A or B. Similar usage of a back-up, cryptic
branch point sequence has been seen in the case of the b-globin gene
[32]. Alternately, perhaps the lariat is simply formed at the mutated
site with lower efficiency [33]. Creation of a doubly-mutant allele will
be needed to identify the back-up branch point conclusively.
Candidate branch point C was not identified in the initial screen
of intron four for splicing-related sequences. As a result, the
mutations made to the polypyrimidine tract overlap the branch
point C consensus sequence by one nucleotide. The splicing defect
seen in lanes five and six and might therefore reflect loss of both
polypyrimidine tract and branch point C function. As loss of branch
point C function alone (lane 4) results in only partial exclusion of
exon five from BAX mRNA, the near total skippingof exon five seen
with these potentially compound mutants indicates a significant
contribution of the polypyrimidine tract to correct BAX splicing.
We made two mutations to the polypyrimidine tract. The second
mutation attempted to alter spliceacceptor site usage by inclusion of
multiple AG dinucleotides (lane six). In this context, the lariat
branchpoint sequence could be provided by the A or B sites and the
polypyrimidine tract by the run of seven Ys between branch points
B and C. (Seven pyrimidines are sufficient for U2AF binding [34].)
We did not observe usage of these potential splice acceptor sites
even by high-throughput DNA sequencing. As the primary purpose
of this mutation was to disrupt the polypyrimidine tract, we did not
include the pyrimidine typically present just 39 of a strong splice
acceptor site. This omission likely accounts for the failure of these
AG dinucleotides to be used as cryptic splice sites. All five of the
cryptic splice sites found by high-throughput DNA sequencing have
a YAG splice acceptor site, whereas only the most abundant has a
readily-identifiable lariat branch point and polypyrimidine tract.
Supporting Information
Figure S1 The full nucleotide sequence of the BAX ZFN
expression plasmid.
(TXT)
Acknowledgments
We thank Ed Rebar, Jeff Miller, Dave Paschon, Lei Zhang, Sarah Hinkley,
George Katibah, Gladys Dulay, Anna Vincent, Stephen Lam, and Rainier
Amora for ZFN construction and cloning, and Michael Holmes, Christine
Guthrie, and Alex Plocik for productive discussion.
Author Contributions
Conceived and designed the experiments: PDG FDU GJC. Performed the
experiments: SC. Analyzed the data: SC FDU GJC. Wrote the manuscript:
PDG FDU GJC.
ZFN-Mediated Analysis of RNA Splicing
PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e16961References
1. Schwartz S, Ast G (2010) Chromatin density and splicing destiny: on the cross-
talk between chromatin structure and splicing. Embo J 29: 1629–1636.
2. Schwartz S, Meshorer E, Ast G (2009) Chromatin organization marks exon-
intron structure. Nat Struct Mol Biol 16: 990–995.
3. Tilgner H, Nikolaou C, Althammer S, Sammeth M, Beato M, et al. (2009)
Nucleosome positioning as a determinant of exon recognition. Nat Struct Mol
Biol 16: 996–1001.
4. Kolasinska-Zwierz P, Down T, Latorre I, Liu T, Liu XS, et al. (2009)
Differential chromatin marking of introns and expressed exons by H3K36me3.
Nat Genet 41: 376–381.
5. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, et al. (2010)
Regulation of alternative splicing by histone modifications. Science 327:
996–1000.
6. Maniatis T, Reed R (2002) An extensive network of coupling among gene
expression machines. Nature 416: 499–506.
7. Proudfoot NJ, Furger A, Dye MJ (2002) Integrating mRNA processing with
transcription. Cell 108: 501–512.
8. Neugebauer KM (2002) On the importance of being co-transcriptional. J Cell
Sci 115: 3865–3871.
9. Bentley D (2002) The mRNA assembly line: transcription and processing
machines in the same factory. Curr Opin Cell Biol 14: 336–342.
10. Kornblihtt AR, de la Mata M, Fededa JP, Munoz MJ, Nogues G (2004) Multiple
links between transcription and splicing. Rna 10: 1489–1498.
11. Hicks MJ, Yang CR, Kotlajich MV, Hertel KJ (2006) Linking splicing to Pol II
transcription stabilizes pre-mRNAs and influences splicing patterns. PLoS Biol
4: e147.
12. Das R, Yu J, Zhang Z, Gygi MP, Krainer AR, et al. (2007) SR proteins function
in coupling RNAP II transcription to pre-mRNA splicing. Mol Cell 26:
867–881.
13. Luo MJ, Reed R (1999) Splicing is required for rapid and efficient mRNA export
in metazoans. Proc Natl Acad Sci U S A 96: 14937–14942.
14. Reed R (2003) Coupling transcription, splicing and mRNA export. Curr Opin
Cell Biol 15: 326–331.
15. Carothers AM, Urlaub G, Grunberger D, Chasin LA (1993) Splicing mutants
and their second-site suppressors at the dihydrofolate reductase locus in Chinese
hamster ovary cells. Mol Cell Biol 13: 5085–5098.
16. Chen IT, Chasin LA (1993) Direct selection for mutations affecting specific
splice sites in a hamster dihydrofolate reductase minigene. Mol Cell Biol 13:
289–300.
17. O’Neill JP, Rogan PK, Cariello N, Nicklas JA (1998) Mutations that alter RNA
splicing of the human HPRT gene: a review of the spectrum. Mutat Res 411:
179–214.
18. Santiago Y, Chan E, Liu PQ, Orlando S, Zhang L, et al. (2008) Targeted gene
knockout in mammalian cells by using engineered zinc-finger nucleases. Proc
Natl Acad Sci U S A 105: 5809–5814.
19. Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, et al. (2008) Establishment
of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger
nucleases. Nat Biotechnol 26: 808–816.
20. Liu PQ, Chan EM, Cost GJ, Zhang L, Wang J, et al. (2009) Generation of a
triple-gene knockout mammalian cell line using engineered zinc-finger nucleases.
Biotechnol Bioeng 106: 97–105.
21. Malphettes L, Freyvert Y, Chang J, Liu P-Q, Chan E, et al. (2010) Highly-
efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields
cells which produce completely nonfucosylated antibodies. Biotechnology and
Bioengineering 106: 774–783.
22. Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, et al. (2005) Highly
efficient endogenous human gene correction using designed zinc-finger
nucleases. Nature 435: 646–651.
23. Hockemeyer D, Soldner F, Beard C, Gao Q, Mitalipova M, et al. (2009)
Efficient targeting of expressed and silent genes in human ESCs and iPSCs using
zinc-finger nucleases. Nat Biotechnol 27: 851–857.
24. Dekelver RC, Choi VM, Moehle EA, Paschon DE, Hockemeyer D, et al. (2010)
Functional genomics, proteomics, and regulatory DNA analysis in isogenic
settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in
the human genome. Genome Res.
25. Orlando SJ, Santiago Y, Dekelver RC, Freyvert Y, Boydston EA, et al. (2010)
Zinc-finger nuclease-driven targeted integration into mammalian genomes using
donors with limited chromosomal homology. Nucleic Acids Res.
26. Cost GJ, Freyvert Y, Vafiadis A, Santiago Y, Miller JC, et al. (2009) BAK and
BAX deletion using zinc-finger nucleases yields apoptosis-resistant CHO cells.
Biotechnol Bioeng 105: 330–340.
27. Kol G, Lev-Maor G, Ast G (2005) Human-mouse comparative analysis reveals
that branch-site plasticity contributes to splicing regulation. Hum Mol Genet 14:
1559–1568.
28. Gao K, Masuda A, Matsuura T, Ohno K (2008) Human branch point consensus
sequence is yUnAy. Nucleic Acids Res 36: 2257–2267.
29. Schwartz SH, Silva J, Burstein D, Pupko T, Eyras E, et al. (2008) Large-scale
comparative analysis of splicing signals and their corresponding splicing factors
in eukaryotes. Genome Res 18: 88–103.
30. Schwartz S, Hall E, Ast G (2009) SROOGLE: webserver for integrative, user-
friendly visualization of splicing signals. Nucleic Acids Res 37: W189–192.
31. Kotecki M, Reddy PS, Cochran BH (1999) Isolation and characterization of a
near-haploid human cell line. Exp Cell Res 252: 273–280.
32. Ruskin B, Greene JM, Green MR (1985) Cryptic branch point activation allows
accurate in vitro splicing of human beta-globin intron mutants. Cell 41:
833–844.
33. Hornig H, Aebi M, Weissmann C (1986) Effect of mutations at the lariat branch
acceptor site on beta-globin pre-mRNA splicing in vitro. Nature 324: 589–591.
34. Sickmier EA, Frato KE, Shen H, Paranawithana SR, Green MR, et al. (2006)
Structural basis for polypyrimidine tract recognition by the essential pre-mRNA
splicing factor U2AF65. Mol Cell 23: 49–59.
ZFN-Mediated Analysis of RNA Splicing
PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e16961